Cytek Biosciences (CTKB) Return on Capital Employed (2021 - 2026)
Cytek Biosciences' (CTKB) quarterly Return on Capital Employed came in at 11.72% in Q1 2026, down 587.0% YoY from 2.41% in Q1 2025, and down 16.19% on a QoQ basis from 10.09% in Q4 2025.
Cytek Biosciences (CTKB) Return on Capital Employed (2021 - 2026) Analysis & Trends
Cytek Biosciences (CTKB) has 6 years of Return on Capital Employed data on file, last reported at 11.72% in Q1 2026.
- Quarterly Return on Capital Employed fell 587.0% year-over-year to 11.72% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 11.72% (down 587.0% YoY) and the FY2025 annual result came in at 10.03%, down 525.0% from the prior year.
- Return on Capital Employed retreated to 11.72% in Q1 2026, from 10.09% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 1.31% in Q1 2022 to a low of 11.72% in Q1 2026.
- A 5-year average of 4.82% and a median of 5.85% in 2025 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2024 — Return on Capital Employed surged 138 bps — and 2026, when it plunged 587 bps.
- Tracing CTKB's Return on Capital Employed over 5 years: stood at 0.39% in 2022, then tumbled by 1477 bps to 6.18% in 2023, then rose by 22 bps to 4.8% in 2024, then plunged by 110 bps to 10.09% in 2025, then dropped by 16 bps to 11.72% in 2026.
- The last three Return on Capital Employed figures came in at 11.72% (Q1 2026), 10.09% (Q4 2025), and 7.59% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.88 Bn | 197.28 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 126.34 Bn | 122.87 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 119.78 Bn | 110.56 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 74.35 Bn | 73.81 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 51.73 Bn | 47.47 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 35.36 Bn | 33.41 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.85 Bn | 31.74 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.23 Bn | 22.91 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | 12.08% |
| 10 | Cytek Biosciences | 620.76 Mn | 546.92 Mn | 28.34 Mn | -12.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -12.28% |
| Mar 31, 2026 | -11.72% |
| Dec 31, 2025 | -10.09% |
| Sep 30, 2025 | -7.59% |
| Jun 30, 2025 | -6.48% |
| Mar 31, 2025 | -5.85% |
| Dec 31, 2024 | -4.80% |
| Sep 30, 2024 | -5.57% |
| Jun 30, 2024 | -5.93% |
| Mar 31, 2024 | -6.04% |
| Dec 31, 2023 | -6.18% |
| Sep 30, 2023 | -5.96% |
| Jun 30, 2023 | -4.21% |
| Mar 31, 2023 | -2.49% |
| Dec 31, 2022 | -0.39% |
| Sep 30, 2022 | -0.13% |
| Jun 30, 2022 | 0.22% |
| Mar 31, 2022 | 1.31% |
| Dec 31, 2021 | 2.15% |
| Sep 30, 2021 | 5.03% |